Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Assets (2020 - 2025)

Historic Assets for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to $163.5 million.

  • SOPHiA GENETICS's Assets fell 796.7% to $163.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.5 million, marking a year-over-year decrease of 796.7%. This contributed to the annual value of $155.3 million for FY2024, which is 2466.43% down from last year.
  • Per SOPHiA GENETICS's latest filing, its Assets stood at $163.5 million for Q3 2025, which was down 796.7% from $177.6 million recorded in Q2 2025.
  • In the past 5 years, SOPHiA GENETICS's Assets registered a high of $334.9 million during Q3 2021, and its lowest value of $104.0 million during Q2 2021.
  • For the 5-year period, SOPHiA GENETICS's Assets averaged around $215.4 million, with its median value being $206.0 million (2023).
  • Over the last 5 years, SOPHiA GENETICS's Assets had its largest YoY gain of 16645.46% in 2022, and its largest YoY loss of 2517.99% in 2022.
  • SOPHiA GENETICS's Assets (Quarter) stood at $320.2 million in 2021, then decreased by 23.84% to $243.8 million in 2022, then decreased by 15.45% to $206.2 million in 2023, then fell by 24.66% to $155.3 million in 2024, then rose by 5.25% to $163.5 million in 2025.
  • Its Assets was $163.5 million in Q3 2025, compared to $177.6 million in Q2 2025 and $146.7 million in Q1 2025.